Wednesday, 7 January 2026

University of Galway announces research partnerships in China

University of Galway has announced two partnerships with leading Chinese medical universities.   The collaborations with Hebei Medical University and Xiangya School of Medicine, Central South University focus on stem cell research and PhD study opportunities.     The announcements were made as part of a trade mission to China led by An Taoiseach Micheál Martin T.D., with the support of Enterprise Ireland.    President of University of Galway, Professor David Burn, said: “University of Galway has developed strong links in China thanks to the excellence of our academic research. We are now seizing the opportunity to build on this and fulfil the promise set out in our Strategy 2025-2030 Of Galway, For the World, and we look forward to the impact that these partnerships can create for society and for healthcare.”   Professor Tim O’Brien, Director of the Regenerative Medicine Institute (REMEDI) at University of Galway, said: “By combining the strengths in regenerative medicine and clinical research at University of Galway with China’s scale, expertise and commitment to innovation, we are hopeful that these partnerships will deliver real benefit for patients and society. The relationships that we have built with these universities in China is international collaboration at its best: forward-looking, people-centred, and focused on shared global impact.”   The transnational education event in Beijing was attended by more than 150 people from 13 higher education institutions in Ireland and China.   University of Galway has renewed a partnership for a Joint Stem Cell Research Centre with Hebei Medical University. The collaboration will enable joint PhD and Masters supervision and collaborative research, including 12 postgraduate opportunities for students Hebei Medical University to enrol in the M.Sc. in Regenerative Medicine & M.Sc. in Cellular Manufacturing and Therapy in University of Galway. The partnership will also seek to drive collaborations between hospitals, universities, and industry in China and Ireland, bringing innovative regenerative stem cell therapies to patients worldwide.   A PhD scholarship Programme is also being renewed with the Chinese Scholarship Council (CSC) which funds up to 10 students from Xiangya School of Medicine to pursue PhD studies in Galway. The collaboration aims to strengthen joint clinical and scientific research between the EU and China, promote academic exchange and deepen institutional links.    Ends 

Friday, 16 December 2022

All eligible University of Galway full time and part time hourly payscales have been updated in line with the provisions of Building Momentum - A New Public Service Agreement 2021-22. Specifically the following increases have been implemented: - With effect from  02nd February 2022, payscales received a 3% increase - With effect from 01st October 2022- payscales received a further 1% increase or €500, whichever is greater  We are still awaiting sanction for the implementation of FEMPI restoration wef 1st July 2022 (save for a limited number of pay scales). Therefore there are no changes to those grades\pensions for now. See paragraph 1.3 in the above link for more details. Further advice will be issued for these grades in due course.

Monday, 24 April 2023

We have been asked to bring to your attention the fact that Secondment Expression of Interest Notices has been issued for the Public Service Transformation Division of the Department of Public Expenditure, NDP Delivery and Reform.  Expressions of interest are invited from across all sectors of the Public Service, including higher education, and across a number of grades.  Notices are available directly at the following link, and DPENDR and DFHERIS would very much appreciate your support in circulating to your staff.   The closing date for applications is 2nd May, and we understand the notices issued on Friday 14th April.